his and hers glp 1 Last week, Hims announced an oral GLP-1 pill. Days later, it was gone. FDA approval exists for a reason. Marketing isn't evidence. Would you trust this company with your health? # Novo Nordisk files lawsuit against

Most users find subcutaneous abdominal injections the most convenient option

We built this company on a foundation of absolute transparency, rigorous scientific standards, and actual customer respect

100% RECYCLABLE PACKAGING: Eco-conscious wellness without compromise

The oral GLP-1 therapies segment held 8% of the market share in 2025 and is expected to grow at the fastest CAGR of 21.8% during the forecast period

Interest in these medications has recently accelerated, although access to and use of GLP-1 RA medications may be impacted by high cost, limited insurance coverage for patients without T2D, and medication shortages

Occasional worsening of heartburn can be treated with proton-pump inhibitors like Nexium